Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
Zhonghua Er Ke Za Zhi ; 60(12): 1339-1341, 2022 Dec 02.
Article in Chinese | MEDLINE | ID: mdl-36444443
2.
Zhonghua Liu Xing Bing Xue Za Zhi ; 42(12): 2100-2105, 2021 Dec 10.
Article in Chinese | MEDLINE | ID: mdl-34954971

ABSTRACT

Objective: To investigate the situation related to HIV infection and influencing factors of traceability efficiency among sex partners of HIV positive men who have sex with men (MSM). Methods: A cross-sectional survey was conducted to investigate the traceability among sex partners of HIV-positive MSM in Ningbo from 2018 to 2020. Limiting-antigen avidity enzyme immunoassay determined recent HIV infection. The classified data was evaluated by chi-square test, and factors of traceability efficiency were analyzed by multivariate logistic regression. Results: A total of 374 newly confirmed HIV-positive MSM were recruited to participate in the HIV test in Ningbo from 2018 to 2020.HIV positive rate of sex partner was 15.7% (75/479,95%CI:12.4%-18.9%). HIV positive rates of sex partner of recent HIV infection MSM was 31.8% (21/66,95%CI:20.3%-43.4%). The proportion of newly confirmed HIV-positive sex partners of recent HIV infection MSM (76.2%) was higher than that of long-term HIV infection MSM (48.1%). The difference was statistically significant (P=0.028). Results from the multivariate logistic regression analysis showed that HIV traceability efficiency was higher in the following subpopulations as; HIV positive MSM who were 36-45 years old (compared with 18-25 years old, OR=3.973,95%CI:1.364-11.569), HIV active detection (compared with HIV passive detection, OR=1.896, 95%CI:1.083-3.319), recent HIV infection MSM (compared with long-term HIV infection MSM, OR=3.733, 95%CI:1.844-7.556). Conclusions: HIV positive rate among partners of HIV positive MSM was very high. The traceability efficiency, which was recent HIV infection MSM and HIV active detection, was high. It is suggested to strengthen the traceability and focus on the newly confirmed HIV-positive MSM in VCT clinics.


Subject(s)
HIV Infections , Sexual and Gender Minorities , Adolescent , Adult , Cross-Sectional Studies , HIV Infections/epidemiology , Homosexuality, Male , Humans , Male , Middle Aged , Risk Factors , Sexual Behavior , Sexual Partners , Surveys and Questionnaires , Young Adult
5.
Zhonghua Bing Li Xue Za Zhi ; 49(1): 52-56, 2020 Jan 08.
Article in Chinese | MEDLINE | ID: mdl-31914535

ABSTRACT

Objective: To investigate the immunohistochemical staining of anaplastic lymphoma kinase (ALK; clone 1A4) in pediatric medulloblastoma (MB). Methods: Molecular subtyping was performed based on the NanoString and sequencing techniques for 44 pediatric MB cases at Children's Hospital, Zhejiang University School of Medicine from 2014 to 2017. ALK expression was detected with EnVision immunhistochemistry using ALK clone 1A4 on whole section. Statistical analyses were performed to evaluate the correlation of protein expression with molecular subgroups. Results: The age ranged from 0.5 to 13.0 years with an average age of 5.8 years. There were 28 males and 16 females, and 31 classic, 5 desmoplastic nodular, 3 extensive nodular and 5 large cell/anaplastic MBs. Except three cases was unable classified, 41 MBs were classified into the four molecular groups: 5 in WNT group, 12 in SHH group, 9 in Group 3 and 15 in Group 4. Thirteen of 44 MB cases were positive staining for ALK, and the positive rate was 29.5%. Six cases were strong reaction, and 7 cases were weak. The expression of ALK at the protein level was associated with the WNT group (P<0.01). The characteristic perinuclear dot-like staining was only showed in WNT group. Conclusions: The ALK immunhistochemistry using antibody clone 1A4 is a useful marker for the molecular subgroup detection of MB. The strong staining and perinuclear dot-like staining indicate as WNT group.


Subject(s)
Cerebellar Neoplasms , Medulloblastoma , Adolescent , Anaplastic Lymphoma Kinase , Child , Child, Preschool , Female , Humans , Infant , Male , Receptor Protein-Tyrosine Kinases
6.
Zhonghua Er Ke Za Zhi ; 55(7): 499-503, 2017 Jul 02.
Article in Chinese | MEDLINE | ID: mdl-28728257

ABSTRACT

Objective: Eosinophilic esophagitis (EoE) is a chronic immune-mediated esophageal disease.The current domestic reports of EoE in children is rare.The aim of this study was to analyze the clinical features, the diagnosis and treatment advance of EoE in children by case analysis and literature review. Method: Clinical data of 22 children with EoE from January, 2011 to December, 2015 in Children's Hospital, Zhejiang University School of Medicine were recorded, retrospective analysis was performed on clinical presentation, gastroendoscopy and histopathological examination features and the treatment. Result: (1) Clinical data: EoE can occur at any age in children (5 months to 13 years). The most common clinical manifestations of EoE are vomiting and abdominal pain, 45% (10/22) and 41%(9/22) respectively. (2) Endoscopy and pathological features of esophageal mucosa: 11 cases with coarse mucous membrane (50%), 6 cases with congestion or erosion of esophageal membrane (27%), 5 cases with longitudinal crack (23%), 3 cases with ring uplift (14%), 3 cases with granular uplift (14%), 3 cases with normal mucosa(14%). Histopathologic manifestation is eosinophil infiltration and the eosinophil counts were all more than or equal to 15/HP. (3) Laboratory results: 13 cases had increasing eosinophil counts and eosinophils proportion (62%). (4)Allergy history: among 22 cases, 7 patients had allergy history (32%). (5) Situation of treatment and remission: 16 cases had clinical remission by oral omeprazole; 2 cases had clinical remission by oral Omeprazole and Montelukast sodium; 1 case acquired remission by elimination diet; 1 case acquired remission by elimination diet and oral prednisone. 2 cases dropped out; Only 2 patients received gastroendoscopy re-examination after 3 months and revealed esophageal mucosal histologic complete recovery. Conclusion: The clinical symptoms of EoE in children varies.Esophageal mucosal features of gastroendoscopy examination in children with EoE were longitudinal crack, white exudates or plaques, paper mucosa, ring uplift and granular uplift.Most patients could achieve remission by using proton-pump inhibitors, only few children needed elimination diet and change formula, or even oral glucocorticoids.


Subject(s)
Eosinophilic Esophagitis , Eosinophils , Child , Eosinophilic Esophagitis/diagnosis , Eosinophilic Esophagitis/therapy , Humans , Mucous Membrane , Retrospective Studies
7.
Zhonghua Er Ke Za Zhi ; 55(4): 298-303, 2017 Apr 02.
Article in Chinese | MEDLINE | ID: mdl-28441828

ABSTRACT

Objective: To understand the clinical manifestation, imaging characteristics and outcomes of pulmonary malignant tumors in children. Method: We retrospectively collected information about seven cases of pulmonary malignant tumors in children in our hospital from Jan 2010 to Dec 2016. The information included clinical manifestation, imaging characteristics, pathologic results, and treatment. Result: (1) All the seven patients firstly visited pediatric internal medicine departments. Symptoms included cough (n=6), dyspnea (n=4), fever (n=2), anorexia (n=2), chest tightness (n=1), chest pain (n=1), lameness (n=1), abdominal distension and constipation (n=1). We did not find hemoptysis, wheezing or weight loss in those patients. Physical examinations revealed unilateral reduced breath sounds (n=5), moist rales and wheezes (n=1), and normal (n=1). Extrapulmonary signs included abdominal distension (n=2), left hip tenderness (n=1), and mass in left scrotum. We did not identify clubbing finger, anemic appearance, lymph node enlargement, or hepatosplenomegaly etc. (2) Laboratory examination results: complete blood count showed white blood cells in normal range except one case (17.44×10(9)/L). Neutrophil percentage ranged from 0.348 to 0.767. C reactive protein ranged between<1 and 162 mg/L. Hemoglobin was normal. Three out of four cases had abnormal blood tumor markers.(3) Imaging results showed multiple nodes (n=3), multiple cystic lesions in lungs (n=2) (both with pleuropulmonary blastoma), endobronchial soft tissue mass (n=1), pulmonary round-shaped mass (n=1), and mediastinal mass (n=1). Imaging results also found atelectasis (n=3), pneumonia (n=2), pneumothorax (n=2), longitudinal diaphragmatic hernia (n=2), pleural effusion (n=1), subcutaneous emphysema (n=1). (4) All the patients underwent tumor puncture biopsy or tumor resection. Pathology revealed the final diagnosis of pleuropulmonary blastoma (n=3), endodermal sinus tumors (n=2), squamous cell carcinoma of lung (n=1), and thyroid papillary carcinoma (n=1). All of them were malignant tumors. We followed up them. Two patients died (both with pleuropulmonary blastoma) after their parents refused any medical help. Two cases were lost to follow-up. Three patients survived (followed up for 19 months, 11 months and tow months, respectively). One case with thyroid papillary carcinoma pulmonary metastasis underwent right thyroid cancer radical plus left thyroid lobe resection plus modified selective central lymph node dissection, then iodine (131) treatment. One case with endodermal sinus tumor pulmonary metastasis underwent three times of chemotherapies, resection of left retroperitoneal tumor and left testicular tumor, and six additional chemotherapies. Another one case of endodermal sinus tumor pulmonary metastasis underwent three times of chemotherapies and was discharged. Conclusion: Pulmonary malignant tumors are rare diseases in children. Clinical signs are often non-specific. For those with chest CT showing multiple cystic lesions, endobronchial soft tissue mass or multiple nodes, but no significant infection manifestation or no response to anti-infection therapy, pulmonary malignant tumors should be considered. Biopsy may be needed to confirm the final diagnosis.


Subject(s)
Carcinoma/diagnosis , Lung Neoplasms/diagnosis , Pulmonary Blastoma/diagnosis , Thyroid Neoplasms/diagnosis , Biopsy, Needle , Carcinoma, Papillary , Child , Cough , Dyspnea , Female , Fever , Humans , Lost to Follow-Up , Lung , Lymph Nodes , Male , Pleural Effusion , Retroperitoneal Neoplasms , Retrospective Studies , Thorax , Thyroid Cancer, Papillary , Tomography, X-Ray Computed
8.
Genet Mol Res ; 15(1)2016 Feb 19.
Article in English | MEDLINE | ID: mdl-26909983

ABSTRACT

We investigated the expression of transforming growth factor-ß1 (TGF-ß1) and connective tissue growth factor (CTGF) in the liver tissue of infants with congenital biliary atresia and neonatal hepatitis, as well as the relationship between the expression of the two factors and liver fibrosis. Thirty-six infants who met the cholestasis criteria were classified into congenital biliary atresia and neonatal hepatitis groups. All specimens were stained with hematoxylin and eosin and Masson's trichrome, and the degree of liver fibrosis was assessed. The scope and level of CTGF and TGF-ß1 expression in the different specimens was evaluated by immunohistochemistry and observation. Liver fibrosis in the congenital biliary atresia group was more advanced than that in the neonatal hepatitis group, and the difference was significant (P < 0.01). In the neonatal hepatitis patients, CTGF and TGF-ß1 were mainly expressed in the hepatocytes, while they were expressed in both hepatocytes and biliary epithelial cells in the congenital biliary atresia patients, and in these patients the expression was significantly stronger than in the neonatal hepatitis patients (P < 0.01). With the aggravation of hepatic fibrosis, CTGF and TGF-ß1 expression levels in liver tissue gradually increased, and their expression levels were significantly correlated (P < 0.01). Liver fibrosis is present in both congenital biliary atresia and neonatal hepatitis patients. The gradual increase of CTGF and TGF-ß1 expression levels in liver tissue is associated with liver fibrosis. Early expression of CTGF and TGF-ß1 in biliary epithelial cells may be involved in the pathogenesis of congenital biliary atresia.


Subject(s)
Biliary Atresia/genetics , Cholestasis/genetics , Connective Tissue Growth Factor/genetics , Hepatitis/genetics , Liver Cirrhosis/genetics , Transforming Growth Factor beta1/genetics , Biliary Atresia/complications , Biliary Atresia/diagnosis , Biliary Atresia/pathology , Cholestasis/complications , Cholestasis/diagnosis , Cholestasis/pathology , Connective Tissue Growth Factor/metabolism , Disease Progression , Eosine Yellowish-(YS) , Epithelial Cells/metabolism , Epithelial Cells/pathology , Female , Gene Expression Regulation , Hematoxylin , Hepatitis/complications , Hepatitis/diagnosis , Hepatitis/pathology , Hepatocytes/metabolism , Hepatocytes/pathology , Humans , Immunohistochemistry , Infant , Liver Cirrhosis/complications , Liver Cirrhosis/diagnosis , Liver Cirrhosis/pathology , Male , Transforming Growth Factor beta1/metabolism
9.
Neuroscience ; 246: 422-34, 2013 Aug 29.
Article in English | MEDLINE | ID: mdl-23597829

ABSTRACT

Many epidemiological reports stated a strong association between maternal infection and development of cerebral palsy, which is a major cause of cognitive impairment. The pathophysiological mechanism of intrauterine inflammation is complex. Recently, it was demonstrated that inflammation has a modulating effect on adult neurogenesis. In this study, we discovered the effect of maternal infection to hippocampal neuronal apoptosis, proliferation and differentiation, and cognitive development in the developing brains of neonatal rats. Morris water maze test was used to assess learning and memory. Terminal deoxynucleotidyl transferase dUTP nick end labeling assay was used to determine neuronal apoptosis, immunostaining was conducted to assess neurogenesis, and Western blot for extracellular signal-regulated kinase (ERK), cyclic AMP responsive element-binding protein (CREB) and brain-derived neurotrophic factor (BDNF) expression in the hippocampus. Results demonstrated that maternal infection increased neuronal apoptosis and significantly impaired spatial learning and memory ability. Maternal infection significantly increased cell proliferation, accompanied by an increased expression of ERK (P3-P7), CREB (P3-P7) and BDNF (P3). On P28, there was no significant difference of cell survival and differentiation in two groups. These results suggest that variation in ERK activity and subsequent expression of its downstream targets, including CREB and BDNF might contribute, at least partially, to modulation of inflammation related cell proliferation, survival and differentiation. Maternal infection increased hippocampal neuronal apoptosis and affected cell proliferation and differentiation in neonatal rats, which may be regarded as an etiological factor in cognitive development impairment.

10.
Nephron Clin Pract ; 111(1): c55-61, 2009.
Article in English | MEDLINE | ID: mdl-19052471

ABSTRACT

BACKGROUND: Kimura disease, often accompanied by nephrotic syndrome, is a rare, chronic inflammatory disorder of unknown cause. In this report, the clinical and histopathological characteristics of 20 Chinese patients with Kimura disease-associated nephrotic syndrome were retrospectively evaluated. METHODS: We report a case of Kimura disease that was diagnosed recently in our ward, with steroid-responsive but recurrent minimal-change nephrotic syndrome. Meanwhile, we also used three powerful Chinese journal search engines (Cqvip.com, Wanfang.data and ScienceChina) to search the cases reported in Chinese from 1984 to 2007. RESULTS: The nephrotic syndrome of our patient occurred 20 months after the onset of Kimura disease. Renal biopsy revealed minimal-change lesions. The patient was responsive to the steroid, but proteinuria recurred. In most of the 19 other cases, the onset of nephrotic syndrome occurred after subcutaneous masses. Renal biopsy in 13 cases showed mesangial proliferative glomerulonephritis in 9, minimal change disease in 2 and membrane nephropathy in 2 cases. Serum creatinine levels were elevated in 5 patients. CONCLUSION: Normally, Kimura disease-associated nephrotic syndrome patients are sensitive to prednisone therapy but are likely to relapse. In patients with recurrent nephrotic syndrome, renal insufficiency is not uncommon.


Subject(s)
Angiolymphoid Hyperplasia with Eosinophilia/complications , Nephrosis, Lipoid/etiology , Nephrotic Syndrome/etiology , Adolescent , Adult , Angiolymphoid Hyperplasia with Eosinophilia/diagnosis , Angiolymphoid Hyperplasia with Eosinophilia/drug therapy , Angiolymphoid Hyperplasia with Eosinophilia/pathology , Biopsy , Child , Child, Preschool , China , Creatinine/blood , Female , Glomerulonephritis, Membranoproliferative/etiology , Glomerulonephritis, Membranoproliferative/pathology , Glomerulonephritis, Membranous/etiology , Glomerulonephritis, Membranous/pathology , Humans , Kidney/pathology , Lymph Nodes/pathology , Male , Middle Aged , Nephrosis, Lipoid/pathology , Prednisone/therapeutic use , Proteinuria/etiology , Recurrence , Young Adult
11.
Eur J Clin Invest ; 38(12): 931-8, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19021718

ABSTRACT

BACKGROUND: Wilms' tumour is the most frequent renal tumour in children. Based on the SIOP strategy, children with Wilms' tumour may benefit from preoperative chemotherapy, but few publications address the effect of preoperative transcatheter arterial chemoembolization (TACE) on patients with Wilms' tumours. The aims of this study were to investigate the prognostic relevance of preoperative TACE followed by tumour resection, proliferating cell nuclear antigen (PCNA) and vascular endothelial growth factor (VEGF) expression in patients with Wilms' tumours. MATERIALS AND METHODS: Two therapeutic strategies including tumour resection only and TACE, followed by tumour resection were conducted in a cohort of 44 patients with Wilms' tumours. Clinical and follow-up data was analysed. Immunohistochemistry staining was used to explore PCNA and VEGF expression in the Wilms' tumour. RESULTS: Two years tumour-free survival of the patients in the TACE group was significantly higher than that of the patients in the control group (P < 0.001) and recurrence and cases of death within one year in the TACE group was markedly lower than that in the control group (P < 0.001). Fifty-five percent of patients in the control group were PCNA-positive vs. 4.17% of patients in the TACE group (P < 0.001). Fifty percent of patients in the control group were VEGF-positive vs. 29.17% of patients in the TACE group (P > 0.05). CONCLUSIONS: Patients with Wilms' tumours benefited from preoperative TACE treatment. PCNA expression was significantly lower in patients in the TACE group than those in the control group. There was no significant difference on VEGF expression between the patients in TACE and control groups.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Chemoembolization, Therapeutic/methods , Kidney Neoplasms/therapy , Proliferating Cell Nuclear Antigen/metabolism , Vascular Endothelial Growth Factor A/metabolism , Wilms Tumor/metabolism , Wilms Tumor/therapy , Biomarkers, Tumor/blood , Case-Control Studies , Child , Child, Preschool , Female , Humans , Immunohistochemistry , Infant , Infusions, Intra-Arterial , Kidney Neoplasms/mortality , Male , Neoplasm Recurrence, Local , Preoperative Care , Prognosis , Survival Rate , Treatment Outcome , Wilms Tumor/mortality
12.
Br J Radiol ; 74(881): 445-7, 2001 May.
Article in English | MEDLINE | ID: mdl-11388993

ABSTRACT

We report a case in which malignant melanoma of the vagina showed some MR signal changes after radiotherapy. Before radiotherapy, the tumour had slightly high signal intensity on T(1) weighted images and was enhanced after gadolinium-DTPA administration. After radiotherapy, the signal intensity of the tumour increased conspicuously on both T(1) weighted images and fat suppression T(1) weighted images.


Subject(s)
Magnetic Resonance Imaging , Melanoma/diagnosis , Vaginal Neoplasms/diagnosis , Contrast Media , Fatal Outcome , Female , Gadolinium DTPA , Humans , Magnetic Resonance Imaging/methods , Melanoma/radiotherapy , Middle Aged , Vaginal Neoplasms/radiotherapy
13.
Eur J Cancer ; 36(9): 1161-70, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10854950

ABSTRACT

Farnesylation of Ras is required for its transforming activity in human cancer and the reaction is catalysed by the enzyme farnesyltransferase. Recently, we discovered a novel chemical series of potent farnesyl pyrophosphate (FPP) analogues which selectively inhibited farnesyltransferase. Our most potent compound to date in this series, A-176120, selectively inhibited farnesyltransferase activity (IC(50) 1.2+/-0.3 nM) over the closely related enzymes geranylgeranyltransferase I (GGTaseI) (IC(50) 423+/-1.8 nM), geranylgeranyltransferase II (GGTaseII) (IC(50) 3000 nM) and squalene synthase (SSase) (IC(50)>10000 nM). A-176120 inhibited ras processing in H-ras-transformed NIH3T3 cells and HCT116 K-ras-mutated cells (ED(50) 1.6 and 0.5 microM, respectively). The anti-angiogenic potential of A-176120 was demonstrated by a decrease in Ras processing, cell proliferation and capillary structure formation of human umbilical vein endothelial cells (HUVEC), and a decrease in the secretion of vascular endothelial growth factor (VEGF) from HCT116 cells. In vivo, A-176120 reduced H-ras NIH3T3 tumour growth and extended the lifespan of nude mice inoculated with H- or K-ras-transformed NIH3T3 cells. A-176120 also had an additive effect in combination with cyclophosphamide in nude mice inoculated with K-ras NIH3T3 transformed cells. Overall, our results demonstrate that A-176120 is a potent FPP mimetic with both antitumour and anti-angiogenic properties.


Subject(s)
Alkyl and Aryl Transferases/antagonists & inhibitors , Enzyme Inhibitors/pharmacology , Polyisoprenyl Phosphates/pharmacology , Animals , Cell Division , Endothelial Growth Factors/metabolism , Endothelium, Vascular/cytology , Farnesyl-Diphosphate Farnesyltransferase/antagonists & inhibitors , Farnesyltranstransferase , Genes, ras/genetics , Humans , Lymphokines/metabolism , Male , Mice , Mice, Nude , Mutation/genetics , Neoplasm Transplantation , Neovascularization, Pathologic , Sesquiterpenes , Transplantation, Heterologous , Tumor Cells, Cultured , Umbilical Veins/cytology , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
14.
Anticancer Drugs ; 10(10): 895-901, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10630357

ABSTRACT

Antiestrogen tamoxifen (Tam) is the most prescribed drug for the treatment of estrogen receptor (ER)-positive breast cancers. It is also used in long-term clinical trials with encouraging preliminary results as a chemopreventive agent for breast cancer. The effect of Tam on ER-negative cancers, however, is unclear. Here we reported that paclitaxel and 4-hydroxytamoxifen (4-HT) have a synergistic cytotoxic effect on the ER-negative colon cancer cell line HCT15, which is refractory to paclitaxel alone. Our results showed that 4-HT at submicromolar concentrations effectively enhanced the antiproliferative effect of paclitaxel. In addition, at 1/10 of the paclitaxel concentrations used for HCT15, 4-HT and paclitaxel also showed synergistic effect on NCI H460, an ER-negative lung cancer cell line. For both cell lines, the effective concentration for paclitaxel to inhibit cell growth was 1 log lower in the combination treatment than the concentration used in the single treatment. Cell cycle analysis showed that the combination of paclitaxel and 4-HT increased the G2/M population and resulted in the increase of apoptosis in both cell lines. Enhanced early release of cytochrome c from mitochondria may be the apoptotic pathway activated in the combination treatment in HCT15 cells.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Colorectal Neoplasms/drug therapy , Estrogen Receptor Modulators/pharmacology , Lung Neoplasms/drug therapy , Paclitaxel/pharmacology , Tamoxifen/analogs & derivatives , Adenocarcinoma/drug therapy , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Apoptosis/drug effects , Carcinoma, Large Cell/drug therapy , Carcinoma, Large Cell/metabolism , Carcinoma, Large Cell/pathology , Cell Division/drug effects , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/pathology , Cytochrome c Group/drug effects , Cytochrome c Group/metabolism , Drug Synergism , Drug Therapy, Combination , G2 Phase/drug effects , Humans , Lung Neoplasms/metabolism , Lung Neoplasms/pathology , Mitochondria/drug effects , Mitochondria/metabolism , Mitosis/drug effects , Receptors, Estrogen/drug effects , Receptors, Estrogen/metabolism , Tamoxifen/pharmacology , Tumor Cells, Cultured
15.
Eur J Cancer ; 35(9): 1394-401, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10658533

ABSTRACT

Ras oncogenes can contribute to tumour development by stimulating vascular endothelial growth factor (VEGF)-dependent angiogenesis. The effect of Ras on angiogenesis may be affected by farnesyltransferase inhibitors (FTI) since farnesylation of Ras is required for its biological activity. In this paper we evaluated the effect of A-170634, a novel and potent CAAX FTI on angiogenesis. Human umbilical vein endothelial cell (HUVEC) tube formation and VEGF secretion were used to assess the effect of A-170634 on angiogenesis in vitro. In vivo, nude mice were injected with the K-ras mutant colon carcinoma cell line HCT116 and treated subcutaneously with A-170634 using osmotic minipump infusion for 10 days. The effect of A-170634 on corneal angiogenesis in vivo was assessed using pellets containing hydron, VEGF, A-170634 or vehicle. In vitro, A-170634 selectively inhibited farnesyltransferase activity over the closely related geranylgeranyltransferase I, inhibited Ras processing, blocked anchorage-dependent and -independent growth of HCT116 K-ras mutated cells, decreased HUVEC capillary structure formation, decreased VEGF secretion from tumour cells and HUVEC growth stimulating activity in a dose-dependent manner. In vivo, tumour growth was decreased by 30% and vascularisation in and around the tumours was reduced by 41% following drug-treatment with no apparent toxicity to the animals. VEGF-induced corneal neovascularisation was reduced by 80% following A-170634 treatment for 7 days. The data presented here demonstrated that A-170634 was a potent and selective peptidomimetic CAAX FTI with anti-angiogenic properties. These results implied that A-170634 may affect tumour growth in vivo by one or more antitumour pathways.


Subject(s)
Alkyl and Aryl Transferases/antagonists & inhibitors , Colonic Neoplasms/drug therapy , Animals , Colonic Neoplasms/blood supply , Endothelial Growth Factors/metabolism , Endothelium, Vascular , Farnesyltranstransferase , Humans , Lymphokines/metabolism , Methionine/analogs & derivatives , Methionine/therapeutic use , Mice , Mice, Nude , Neovascularization, Pathologic/prevention & control , Pyridines/therapeutic use , Rats , Tumor Cells, Cultured , Umbilical Veins , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
16.
Int J Immunopharmacol ; 20(8): 389-400, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9778100

ABSTRACT

The effects of purified triptolide, a diterpenoid triepoxide compound derived from the Chinese traditional anti-rheumatic medicinal plant extract, Tripterygium wilfordii Hook f (TWHf), were determined in type II collagen-induced arthritis (CIA) in rats. Lewis rats were immunized with bovine type II collagen and treated with purified triptolide 0.1 mg/kg/day or control (vehicle for triptolide) by daily gavage feedings for 28 days. Triptolide was well-tolerated with no evidence of toxicity. Treatment with triptolide resulted in significant delay in time to onset of arthritis (P = 0.039), as well as significantly decreased arthritis incidence (P = 0.024), clinical arthritis severity score (P < 0.0001), histopathological arthritis severity score (P < 0.0001), and in vivo cell-mediated immunity to collagen (P = 0.0004). Triptolide appeared to be a potent immunomodulatory inhibitor of CIA in rats and this may account for the previously observed anti-rheumatic properties of crude extracts of TWHf, although more extensive studies will be needed to confirm these effects.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Arthritis, Experimental/prevention & control , Collagen/antagonists & inhibitors , Diterpenes/therapeutic use , Immunosuppressive Agents/therapeutic use , Phenanthrenes , Animals , Antibodies/blood , Arthritis, Experimental/immunology , Arthritis, Experimental/pathology , Cattle , Collagen/immunology , Epoxy Compounds , Female , Hindlimb , Hypersensitivity, Delayed/chemically induced , Hypersensitivity, Delayed/immunology , Pilot Projects , Rats , Rats, Inbred Lew
17.
Acad Radiol ; 3(5): 418-22, 1996 May.
Article in English | MEDLINE | ID: mdl-8796695

ABSTRACT

RATIONALE AND OBJECTIVES: Percutaneous methods have been used to treat primary and secondary hepatic neoplasms. In the current study, we evaluated the potential of bipolar radiofrequency (RF) electrocautery to increase in vitro liver tissue destruction when compared with monopolar RF electrocautery. METHODS: Two needles (electrodes) were placed into fresh bovine liver tissue for use with bipolar electrocautery. Needle tip exposure was kept constant at 3 cm while other parameters, including treatment time, power (wattage), interneedle distance, and needle tip temperature, were changed. Pathologic and histologic correlation was performed, and tissue necrosis was weighed in grams for individual parameters. RESULTS: There was a minimal threshold of approximately 45 degrees C where tissue coagulation occurred. Tissue coagulation increased the longer treatment went on. Increasing temperature, wattage, or both increased tissue coagulation such that necrosis was too rapid and char formation occurred, which prevented further coagulation. For all wattages and temperatures, there was increasing tissue necrosis with increasing needle separation, until a point at which further needle separation produced less tissue necrosis. Optimizing parameters allowed tissue coagulation of greater than 30 g. CONCLUSION: Bipolar RF electrocautery shows promise for increasing the tissue coagulation in fresh bovine liver compared with the previously described monopolar technique.


Subject(s)
Electrocoagulation/methods , Liver/surgery , Animals , Cattle , Electrodes, Implanted , Liver/pathology , Liver Neoplasms/surgery , Necrosis
18.
Int J Immunopharmacol ; 17(5): 351-6, 1995 May.
Article in English | MEDLINE | ID: mdl-7591358

ABSTRACT

Crude extracts derived from the root of Tripterygium wilfordii Hook f (TWHf) have previously been demonstrated to have immunosuppressive properties and have been used as anti-rheumatic therapy in Chinese traditional medicine. Although these extracts contain a large number of chemical components, the precise nature of the compound(s) responsible for this therapeutic effect has not been established with certainty. An aqueous extract of TWHf was resolved into chemical components by medium-pressure and high-performance liquid chromatography. Immunosuppressive fractions were identified with a mixed lymphocyte reaction (MLR) and chemically characterized by nuclear magnetic resonance spectroscopy and mass spectrometry. Two major peaks of immunosuppressive activity were identified. These were the closely related diterpenoid triepoxides, triptolide and tripdiolide. No other immunosuppressive compounds were identified using MLR as the biologic screening assay. Triptolide and tripdiolide may be responsible for the anti-rheumatic properties of crude aqueous extracts of TWHf and represent a novel class of immunosuppressive drugs with potential clinical utility.


Subject(s)
Diterpenes/isolation & purification , Immunosuppressive Agents/isolation & purification , Phenanthrenes , Animals , Cells, Cultured , Chromatography, High Pressure Liquid , Chromatography, Thin Layer , Diterpenes/chemistry , Diterpenes/pharmacology , Drugs, Chinese Herbal/pharmacology , Epoxy Compounds , Immunosuppressive Agents/pharmacology , Lymphocyte Culture Test, Mixed , Magnetic Resonance Spectroscopy , Mass Spectrometry , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Spleen/immunology
19.
J Magn Reson Imaging ; 4(1): 37-42, 1994.
Article in English | MEDLINE | ID: mdl-8148554

ABSTRACT

The goal of the study was to establish normal carotid artery flow rates in left-handed and right-handed individuals as a standard against which patients with carotid artery disease could be compared. Antegrade and retrograde flow were measured in the ascending aorta, in the right and left common, internal, and external carotid arteries, and in the vertebral arteries of 12 healthy subjects. Five subjects were right-handed, five left-handed, and two ambidextrous. Measured flow rates were as follows: common carotid arteries, 360-557 mL/min (mean [+/- standard deviation], 465 mL/min +/- 52); internal carotid arteries, 132-367 mL/min (mean, 265 mL/min +/- 60); external carotid arteries, 113-309 mL/min (mean, 186 mL/min +/- 51); vertebral arteries from 133-308 mL/min (mean, 244 mL/min +/- 43); and cerebral circulation, 546-931 mL/min (mean, 774 mL/min +/- 134). All right-handed subjects had higher flow rates in the left internal carotid artery than in the right, and all left-handed subjects had higher flow rates in the right internal carotid artery (P = .007). There were no significant differences in left and right common carotid artery flow rates between left- and right-handed subjects. The standard deviation of a single measurement was 5%. The flow rates were similar to those obtained previously with other techniques and could be used as a normal standard.


Subject(s)
Carotid Arteries/anatomy & histology , Cerebrovascular Circulation/physiology , Vertebral Artery/anatomy & histology , Adult , Blood Flow Velocity/physiology , Carotid Arteries/physiology , Female , Functional Laterality/physiology , Humans , Magnetic Resonance Imaging/methods , Male , Reference Values , Vertebral Artery/physiology
20.
Arthritis Rheum ; 35(11): 1381-6, 1992 Nov.
Article in English | MEDLINE | ID: mdl-1445458

ABSTRACT

OBJECTIVE: Treatment of MRL-lpr/lpr mice with Tripterygium wilfordii Hook f (TWHf) to evaluate its effects on mortality, renal disease, and arthritis. METHODS: Mice were fed water (group A, control), TWHf (group B), or first water and then TWHf (group C) from age 7 weeks until age 21 weeks. RESULTS: Arthritis and glomerulonephritis were decreased in groups B and C mice, and survival was increased in group B mice. CONCLUSION: TWHf decreases the mortality rate, and severity of glomerulonephritis and arthritis in MRL-lpr/lpr mice.


Subject(s)
Arthritis/prevention & control , Kidney Diseases/prevention & control , Lupus Erythematosus, Systemic/complications , Mice, Mutant Strains , Plant Extracts/pharmacology , Animals , Arthritis/immunology , Arthritis/pathology , Female , Hindlimb , Joints/pathology , Kidney/pathology , Kidney Diseases/immunology , Kidney Diseases/pathology , Lupus Erythematosus, Systemic/genetics , Lupus Erythematosus, Systemic/mortality , Lymph Nodes/pathology , Mice , Proteinuria/prevention & control , Survival Analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...